Expression of ApoE4 has been linked to higher risk of AD with earlier onset (Blacker et al., 1997) and is believed to be related to dysfunctional clearance of amyloid-beta from the brain (Castellano et al., 2011; Hawkes et al., 2012). This evidence concerns the gene APOE and Alzheimer disease.